ConductScience.org, home

Paper34636151

Comparison of renal remission and relapse-free rate in initial- and delayed-onset lupus nephritis.

Suzuki E and 11 others. Int J Rheum Dis, 2021. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Comparison of renal remission and relapse-free rate in initial- and delayed-onset lupus nephritis. Papers, record 34636151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34636151

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparison of renal remission and relapse-free rate in initial- and delayed-onset lupus nephritis.
PubMed
Journal
Int J Rheum Dis
PubMed
Year
2021
PubMed
Publication types
Journal Article, Multicenter Study, Observational Study
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.83
iCite
Revised in PubMed
2022-07-31
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Suzuki EEijihttps://orcid.org/0000-0001-9042-4947
2Yashiro-Furuya MMakiko
3Temmoku JJumpei
4Fujita YYuya
5Matsuoka NNaoki
6Hazama MMomoko
7Asano TTomoyuki
8Sato SShuzo
9Kobayashi HHiroko
10Watanabe HHiroshi
11Kanno TTakashi
12Migita KKiyoshi

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Lupus NephritisMajor topic
Remission InductionMajor topic
Adult
Disease Progression
Female
Humans
Immunosuppressive Agents
Male
Recurrence
Retrospective Studies
Risk Factors
Time Factors

Source PubMed

Download CSV of topics

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127821390Update on Lupus Nephritis.Clin J Am Soc Nephrol2017https://conductscience.org/library/papers/27821390PubMed
219369404Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis.J Am Soc Nephrol2009https://conductscience.org/library/papers/19369404PubMed
325018937Chapter 12: Lupus nephritis.Kidney Int Suppl (2011)2012https://conductscience.org/library/papers/25018937PubMed
412079714Demographic differences in the development of lupus nephritis: a retrospective analysis.Am J Med2002https://conductscience.org/library/papers/12079714PubMed
514717922The classification of glomerulonephritis in systemic lupus erythematosus revisited.Kidney Int2004https://conductscience.org/library/papers/14717922PubMed
622556106American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis.Arthritis Care Res (Hoboken)2012https://conductscience.org/library/papers/22556106PubMed
725563691Early achievement of complete renal response predicts good long-term renal outcome and low systemic damage in newly diagnosed lupus nephritis class III or IV.Mod Rheumatol2015https://conductscience.org/library/papers/25563691PubMed
822129255Systemic lupus erythematosus.N Engl J Med2011https://conductscience.org/library/papers/22129255PubMed
930442061Late-onset biopsy-proven lupus nephritis without other associated autoimmune diseases: severity and long-term outcome.Lupus2019https://conductscience.org/library/papers/30442061PubMed
10309267222019 update of the EULAR recommendations for the management of systemic lupus erythematosus.Ann Rheum Dis2019https://conductscience.org/library/papers/30926722PubMed
1122052624Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality.Arthritis Care Res (Hoboken)2012https://conductscience.org/library/papers/22052624PubMed
1231180030Management strategies and future directions for systemic lupus erythematosus in adults.Lancet2019https://conductscience.org/library/papers/31180030PubMed
1315334470Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis.Arthritis Rheum2004https://conductscience.org/library/papers/15334470PubMed
1414747370The classification of glomerulonephritis in systemic lupus erythematosus revisited.J Am Soc Nephrol2004https://conductscience.org/library/papers/14747370PubMed
1531296139Delayed lupus nephritis in the course of systemic lupus erythematosus is associated with a poorer treatment response: a multicentre, retrospective cohort study in Japan.Lupus2019https://conductscience.org/library/papers/31296139PubMed
1629314776Chronicity index, especially glomerular sclerosis, is the most powerful predictor of renal response following immunosuppressive treatment in patients with lupus nephritis.Int J Rheum Dis2018https://conductscience.org/library/papers/29314776PubMed
1718413438Delayed lupus nephritis.Ann Rheum Dis2008https://conductscience.org/library/papers/18413438PubMed
1822851469
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.
Ann Rheum Dis2012https://conductscience.org/library/papers/22851469PubMed
199324032Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.Arthritis Rheum1997https://conductscience.org/library/papers/9324032PubMed
2018003764Value of a complete or partial remission in severe lupus nephritis.Clin J Am Soc Nephrol2008https://conductscience.org/library/papers/18003764PubMed

See all 31 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
38648778Risk of chronic kidney disease in 260 patients with lupus nephritis: analysis of a nationwide multicentre cohort with up to 35 years of follow-up.Rheumatology (Oxford)2025https://conductscience.org/library/papers/38648778PubMed
38247126Predictors of renal relapse in Koreans with lupus nephritis after achieving complete response: a 35-years of experience at a single center.Korean J Intern Med2024https://conductscience.org/library/papers/38247126PubMed
34636151Comparison of renal remission and relapse-free rate in initial- and delayed-onset lupus nephritis.Int J Rheum Dis2021https://conductscience.org/library/papers/34636151PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213NCBI Gene
C3718PubTator's text mininghttps://conductscience.org/library/genes/718NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34636151

GET https://conductscience.org/api/papers/v1/34636151/references?page=2